Morgan Stanley Maintains Equal-Weight on Allstate, Lowers Price Target to $240
Morgan Stanley analyst Bob Huang maintains Allstate (NYSE:ALL) with a Equal-Weight and lowers the price target from $265 to $240.
Stocks · News reference
Elizabeth Warren, Josh Hawley Launch Probe Into Insurance Giants Over Claims That End With $0 Payouts — State Farm, Allstate Face Tough Questions: Report (UPDATED)
Warren and Hawley are pressing insurers like State Farm and Allstate to explain why more home and auto claims go unpaid.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Goldman Sachs Maintains Neutral on Allstate, Lowers Price Target to $250
Shares of financial companies are trading lower. The sector may be under pressure as traders rotate into the tech space after recent e-commerce and payments partnerships with Meta's Muse AI agent threaten to disrupt traditional financial companies.
Texas AG Targets UnitedHealth: Probe Examines Alleged Bribes, Care Delays and Coverage Denials
Texas AG Ken Paxton is investigating UnitedHealth Group over allegations of illegal care delays, coverage reversals, and Medicare fraud.
CNBC Halftime Report Final Trades: UnitedHealth Group, EQT, Clearway Energy, Goldman Sachs Nasdaq-100 Premium Income ETF
Live On CNBC, Kevin Simpson Announces Bought More UnitedHealth Group; Sold IBM